Abeona Therapeutics Inc.

Contributing Author

Recent Articles by Abeona Therapeutics Inc.

13 hours	Abeona Therapeutics Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy ABEO GlobeNewswire
13 hours	Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
Jun-30	Abeona Therapeutics added to Membership of U.S. Small-cap Russell 2000 Index and Broad-market Russell 3000 Index ABEO GlobeNewswire
Jun-24	Abeona Therapeutics Announces Publication in The Lancet of Phase 3 VIITAL Study Data in Recessive Dystrophic Epidermolysis Bullosa ABEO GlobeNewswire
Jun-02	Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
May-30	Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference ABEO GlobeNewswire
May-15	Abeona Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates ABEO GlobeNewswire
May-14	UPDATE -- Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYN Gene Therapy to Treat Wounds in Painful Skin Disorder ABEO GlobeNewswire
May-14	Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder ABEO GlobeNewswire
May-14	Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYN Gene Therapy to Treat Wounds in Painful Skin Disorder ABEO GlobeNewswire
May-12	Abeona Therapeutics Enters into Agreement to Sell Priority Review Voucher for $155 Million ABEO GlobeNewswire
May-07	Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire